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ypertension is a complex disorder that represents one of the most important risk factors for myocardial infarction, stroke, end-stage renal disease, and peripheral vascular disease. 1 It is influenced by environmental as well as by genetic factors. The genetic contribution is estimated to be between 30% and 40% of blood pressure (BP) variation. 2, 3 Several susceptibility genes for hypertension showing Mendelian inheritance have been identified to date, 1 but their contribution to BP variation in the general population is very small. Searching for genes that contribute to the complex form of hypertension has been much less successful. In recent years, a series of genes have been proposed to influence BP and the evidence of the association with hypertension has been shown for some of them. 4 -6 However, these associations were not always confirmed. [7] [8] [9] Genes encoding components of the renin-angiotensin system (RAS) have been proposed as candidate genes for hypertension, as RAS is a well-known pathophysiologic pathway involved in BP regulation. The RAS genes encoding angiotensinogen (AGT), angiotensin-1-converting enzyme (ACE), and angiotensin II type 1 receptor (AT1R) have been extensively studied and their involvement in the development of hypertension has been analyzed by linkage and association studies in various populations.
The most extensively studied polymorphism in the ACE gene is the Alu insertion polymorphism (ACE I/D) in intron 16 of the gene, which is known to be associated with plasma ACE level. 12, 13 The ACE I/D polymorphism is presumed to be in linkage disequilibrium with functional variant that determines ACE plasma level.
14 However, in spite of a great number of polymorphisms detected in ACE gene, including the T-3892C polymorphism in the DNA upstream of gene, 15 the functional variant has not yet been identified. Although there is strong evidence that there is a variant in the ACE gene that influences ACE plasma level, the available data on ACE gene influence on the development of hypertension are conflicting. 5, 8, 16 However, two large population-based studies found linkage evidence and significant association of I/D with hypertension, which was restricted to men. 5, 17 Moreover, strong evidence for a quantitative trait locus for BP on chromosome 17, which was close to the ACE gene, was found by a genome scan analysis. 18 The potential role of AGT gene in hypertension was originally explored by Jeunemaitre et al. 4 Among the 15 molecular variants of AGT that had been identified, significant association with hypertension was observed with two amino acid substitutions -M235T and T174M. The results of subsequent studies that tried to detect an association between these two variants and hypertension have been contradictory. 7, 10 The polymorphism A1166C in the 3= untranslated region of the AT1R gene was detected by Bonnardeaux et al, 6 who also identified its association with hypertension. Subsequent studies yielded conflicting results. 9 In the present case-control study we examined possible associations between polymorphisms of the AGT, ACE, and AT1R genes and hypertension in the Croatian population under 40 years of age. Being aware of the composite nature of hypertension with the cumulative effects of environmental risk factors in the course of life we chose a sample of relatively young adults assuming that the genetic influence on hypertension might be more clearly detected. We studied I/D and T-3892C polymorphisms in ACE gene, M235T and T174M in AGT gene, and A1166C in AT1R gene.
Methods

Study Population
The study sample was extracted from a broader sample of 10,074 participants that was collected from 1995 to 1996 within the subproject "Health Promotion" included in the First Croatian Health Project. 19 The participants were adult volunteers aged 18 to 80 years from 30 randomly selected settlements belonging to all four major geographic regions of Croatia. A stratified multistage sampling design was used that provided the sample with a known probability distribution for the variables of age and sex. The age group of 18 to 40 years numbered 4115 participants, which was 2.6% of the population of Croatia falling in that age range (according to the 1991 census). From all hypertensive participants aged 18 to 40 years, 119 cases were selected randomly for the purpose of this study. The control group (N ϭ 125) was chosen by matching cases with respect to age, sex, and place of residence.
Our criteria for selection of hypertensive participants were the following: 1) BP more than 140 mm Hg for systolic pressure or 90 mm Hg for diastolic pressure and 2) history of hypertension as assessed by patient interview. The probability of inclusions of persons suffering from secondary hypertension was minimized using detailed health questionnaire.
Arterial BP (systolic and diastolic) was measured twice and the lower value was taken into account. The measurement was performed on the left upper arm by auscultation method after the subject had been seated for at least 15 min. Mercury sphygmomanometers were used and the appropriate adult cuff size (medium or large) was applied.
Body height and weight were measured according to the International Biology Programme (IBP) protocols 20 and used to calculate body mass index (BMI ϭ weight [in kilograms]/height 2 [in meters squared]). Data on blood triglycerides and cholesterol levels were also available. 19 Basic characteristics of the sample are shown in Table 1 . All the participants gave their informed consent.
DNA Analysis
Samples of venous blood were collected in EDTA tubes for extraction of DNA from whole blood by using the salting-out procedure.
Genotyping of the ACE I/D polymorphism was performed after polymerase chain reaction amplification of the region encompassing the polymorphism with three primers as described by Harrap et al 21 and detection of fragments on 2% agarose gel. The genotypes of T-3892C in ACE gene, M235T and T714M polymorphisms in AGT gene, and A1166C polymorphism in the AT1R gene were detected by allele-specific oligonucleotide hybridization as described previously. 6, 15, 22 BMI ϭ body mass index; DBP ϭ diastolic blood pressure; SBP ϭ systolic blood pressure.
Statistical Analysis
For each polymorphism, allele frequencies were calculated from genotype frequencies in cases and controls. Deviation from Hardy-Weinberg equilibrium was assessed by the 2 -test with 1 df. In the control group, the 2 -test was also used to test the differences in genotype distributions among four geographic regions of Croatia. Because no statistically significant differences were found, we assumed the homogeneity of Croatian population with respect to polymorphisms studied, and further analyses were carried out on total samples of cases and controls. Differences in genotype and allele distributions between cases and controls were tested by the 2 -test with 2 df and 1 df, respectively. To compare the prevalence of hypertension among the genotypes of each polymorphism, genotypic odds ratios (OR) for hypertension were estimated using logistic regression analysis. The same analysis was used to calculate ORs for combined effects of sex, age, BMI, triglycerides and cholesterol blood concentrations, and genotypes on hypertension. The BMI was compared across genotypes by univariate analysis of variance.
Pairwise linkage disequilibrium (D) was estimated as D ϭ P 11 Ϫ p 1 q 1 , where P 11 is the frequency of haplotype A 1 B 1 , and p 1 and q 1 are the frequencies of alleles A 1 and B 1 at loci A and B, respectively. The value of linkage disequilibrium was expressed as Lewontin's coefficient. 23 Haplotype frequencies were estimated by the expectationmaximization algorithm. 24 A value of P Յ .05 was considered statistically significant for all statistical tests.
Results
Genotype distributions of all five studied polymorphisms were compatible with Hardy-Weinberg expectation in cases as well as in controls. Differences between cases and controls in genotype distributions were observed for both ACE gene polymorphisms (Table 2) with DD genotype of I/D polymorphism and CC genotype of T-3892C polymorphism being more prevalent in cases than in controls. Genotype distributions of other polymorphisms investigated in AGT and AT1R genes did not differ between these two groups. The difference in allele distributions was only observed for ACE I/D with the D allele being more frequent in cases (56.7% v 45.5% in controls).
To test the association of ACE gene polymorphisms with hypertension, genotypic ORs were calculated. Taking the II genotype of the ACE I/D polymorphism as a reference, the OR for hypertension associated with the ID genotype was 0.97 (95% confidence interval [CI] 0.51-1.83) and the OR associated with the DD genotype was 2.50 (95% CI 1.19 -5.25), indicating a recessive effect of the D allele on risk (Table 3) . A similar situation was observed for the T-3892C polymorphism in the ACE gene. Taking TT genotype as a reference, the OR for hypertension associated with the CT genotype was 0.82 (95% CI 0.47-1.45) and that associated with the CC genotype was 2.32 (95% CI 1.05-5.10).
The LD between the two studied polymorphisms in the ACE gene-expressed as Lewontin's coefficient D=-was Ϫ0.85. Such a high LD between two polymorphisms having similar allele frequencies suggests that their association with hypertension may have the same source, which might possibly be a third polymorphism in LD with the ones investigated.
The OR associated with the combination of DD and CC genotypes versus all other combinations was 2.57 (95% CI 1.20 -5.52), that is, very similar to the one observed in the separate analyses of these two polymorphisms (Table 3) . To unravel the possible influence of several risk factors for hypertension -sex, age, BMI, and triglyceride and cholesterol concentrations -on the development of hypertension in the sample, these factors were incorporated as independent variables in the multivariate logistic regression together with ACE I/D genotypes (Table 4 ). In addition to the DD genotype that had in the univariate analysis already been shown as a significant predictor for the presence of hypertension, the multivariate analysis revealed BMI as another significant predictor (OR 1.15 with 95% CI 1.07-1.23). To check for independent influence of BMI and ACE on hypertension, the distribution of BMI was tested across the ACE genotypes. The univariate F of 0.274 for controls (df ϭ 2 and 118; P ϭ .761) and 0.001 for cases (df ϭ 2 and 115; P ϭ .999) indicated that there were no differences in BMI distributions among the genotypes within each group.
The relationship between BMI and hypertension across ACE I/D genotypes is illustrated in Fig. 1 where BMI is shown as a categorical variable with the cutoff point of 30 kg/m 2 that separates nonobese and obese subjects. 25 The proportions of hypertensives across BMI and genotype clearly indicate the additive effect of obesity and ACE DD genotype. In nonobese ACE II and ID groups, the proportions of hypertensive cases are at the 40% level. In the obese with these genotypes, the proportions increase up to the level found in the nonobese DD group (60%). The proportion of hypertensives is as high as 86% in the obese DD group.
Discussion
In this study, we performed an association analysis of hypertension with polymorphisms in genes encoding components of the RAS in a general population sample from Croatia younger than 40 years of age. We chose to sample younger persons to enhance the detection of the genetic influence on hypertension assuming a stronger genetic component if the affected individuals are of a younger age. Because case-control studies may suffer from several biases that may lead to false-positive and false-negative results, we have matched our case and control groups for age, sex, and place of residence, thus minimizing the biases.
Among the three RAS genes we found that only the polymorphisms in the ACE gene showed an association with hypertension. The association of DD genotype of ACE I/D polymorphism suggested the recessive effect of Abbreviations as in Table 3 . Significance: * P ϭ .04; † P ϭ .001. this susceptibility allele on the risk. A similar association was observed for the Ϫ3892 CC genotype. As these two polymorphisms are in strong LD, the association observed for each genotype separately probably reflects the same mechanism. Despite the strong evidence from both association and linkage studies that the ACE D allele influences ACE plasma levels 12, 13 the data on its association with hypertension as well as on increased angiotensin II (potent vasoconstrictor molecule) levels are contradictory. 5, 8, 16, 17, 21, 26 However, ACE may also influence BP regulation through the degradation of bradykinin, a strong vasodilator and suppressor of smooth muscle cell growth. Some studies have shown that bradykinin concentration is decreased in hypertension 27 and Brown et al 28 have reported an association of the ACE D allele with increased degradation of bradykinin.
FIG. 1.
The lack of association between ACE polymorphisms and hypertension in initial studies 8, 29 led to the opinion that ACE polymorphisms are not involved in the pathogenesis of hypertension. Recently, however, two large population-based studies found the evidence of both linkage and significant association of the I/D polymorphism with hypertension, which were restricted to male subjects. 5, 17 Furthermore, a genome scan analysis revealed strong evidence of a quantitative trait locus for BP on chromosome 17 in the proximity of the ACE gene. 18 Our negative findings on the association of the polymorphisms in other two studied genes with hypertension are in accordance with some of the published articles. 7, 9, 10 Jeunemaitre et al 30 state that such findings may result from the small sample sizes that lack the statistical power to detect differences. The same remark may generally be applied to this study. The lack of association of the polymorphisms in AGT and AGT1R genes with hypertension may likewise be the consequence of the small sample size.
Among the several known risk factors for hypertension (sex, age, BMI, triglyceride and cholesterol blood concentrations), BMI was the only significant predictor for the presence of hypertension. The DD genotype and BMI seem to act independently on the development of hypertension as BMI distribution is the same regardless of ACE I/D genotype.
Finding of 86% of hypertensives among the subjects having both DD genotype and BMI Ն30 kg/m 2 -compared to 60% of those having only one of these two risk factors and 40% of those having neither of them -is consistent with an additive effect of DD genotype and obesity. Moreover, similar frequencies of obese and nonobese cases in both II and ID genotypes confirm the recessive nature of ACE I/D polymorphism, that is, the influence of ACE I/D on hypertension only in the case of the presence of two D alleles (Table 3 , Fig. 1 ).
In conclusion, the present study detected the association of ACE gene polymorphisms with premature hypertension, whereas no association with AGT and AT1R gene polymorphisms was obtained. Among several known risk factors for hypertension, BMI was the only one found to be associated with its development, acting independently from the ACE gene.
